Hindustan Organic Chemicals Q1 Results: Net profit turns positive at ₹3.69 crore
Hindustan Organic Chemicals Ltd posted a Q1FY26 standalone net profit of ₹3.69 crore, reversing a YoY loss. Revenue fell 41% to ₹95.99 crore. The Board highlighted SEBI compliance breaches regarding independent director vacancies and ongoing subsidiary delisting processes.

*this image is generated using AI for illustrative purposes only.
Hindustan Organic Chemicals turned profitable in the first quarter of FY26, reporting a standalone net profit of ₹3.69 crore compared to a loss of ₹6.50 crore in Q1FY25. Revenue from operations declined to ₹95.99 crore from ₹163.89 crore year-on-year, driven by lower operational activity. The profit turnaround was supported by a reduction in cost of materials consumed and favorable inventory adjustments. However, the filing highlights significant corporate governance concerns, including non-compliance with SEBI listing regulations regarding board composition.
The Board of Directors approved the unaudited financial results on August 7, 2026, pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Statutory Auditors Balan & Co., Chartered Accountants, issued an unmodified opinion on both standalone and consolidated financials. The Audit Committee did not review the results due to an absence of quorum among independent directors, as required by Clause A(5) of Part C of Schedule II of the SEBI LODR Regulations.
Financial Performance
Standalone revenue from operations fell to ₹95.99 crore in Q1FY26 from ₹163.89 crore in Q1FY25. Total income decreased to ₹100.29 crore from ₹169.08 crore. Cost of materials consumed dropped significantly to ₹68.34 crore from ₹120.57 crore. A decrease in inventories contributed ₹12.76 crore to income, whereas an increase had impacted the prior year. Finance costs remained stable at ₹4.95 crore. The company reported no tax expenses due to its loss-making position in previous years and current profitability levels not triggering immediate tax liabilities.
| Metric | Q1FY26 (₹ lakhs) | Q1FY25 (₹ lakhs) | Change |
|---|---|---|---|
| Revenue from Operations | 9,599.62 | 16,388.80 | -41.4% |
| Total Income | 10,028.96 | 16,908.18 | -40.7% |
| Total Expenses | 9,659.53 | 18,272.52 | -47.1% |
| Net Profit/(Loss) | 369.43 | (649.88) | Turnaround |
| EPS (Basic) | ₹0.55 | (₹0.97) | Positive |
Consolidated net profit for the period was ₹383.98 lakh, comprising ₹369.43 lakh from continuing operations and ₹14.55 lakh from discontinued operations related to its subsidiary, Hindustan Fluorocarbons Limited. Basic earnings per share for continuing operations were ₹0.55, up from a loss of ₹0.97 per share in the corresponding quarter last year.
Governance and Compliance Issues
The company disclosed material non-compliance with Regulation 17(1)(b), Regulation 17(1)(c), and Regulation 17(1E) of the SEBI LODR Regulations, 2015. The tenure of Non-Official Independent Director Vinay Kumar Sharma ended on June 4, 2026, reducing the number of independent directors to one. This resulted in a failure to meet the requirement of half the board strength being independent directors and a minimum of six directors between June 5 and June 30, 2026. Consequently, the Audit Committee and Nomination & Remuneration Committee could not meet quorum requirements under Regulation 18 and Regulation 19 of SEBI LODR and Sections 177 and 178(1) of the Companies Act, 2013. The vacancy remains unfilled, and the matter has been taken up with the Administrative Ministry.
Subsidiary and Restructuring Updates
Hindustan Fluorocarbons Limited, the subsidiary, was delisted from BSE Limited effective February 6, 2026. During FY26, Hindustan Organic Chemicals acquired an additional 2,66,741 equity shares of the subsidiary at ₹17.76 per share. The subsidiary transferred ₹1,362.03 lakh from fixed deposits to an escrow account maintained by the holding company to settle outstanding loans and interest. A Scheme of Amalgamation for the merger of the subsidiary with the holding company has been proposed by the Board, pending regulatory approvals. The holding company continues to implement a Government-approved restructuring plan, with the sale of unencumbered land at Rasayani and Panvel in progress.
Historical Stock Returns for Hindustan Organic Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.35% | +10.56% | +1.03% | +31.13% | +8.28% | +4.80% |
How might the prolonged vacancy of independent directors and lack of Audit Committee quorum impact investor confidence and potential regulatory penalties from SEBI?
What is the expected timeline for regulatory approval of the amalgamation scheme with Hindustan Fluorocarbons Limited, and how will this consolidation affect future operational synergies?
Given the 41% year-on-year revenue decline, what specific operational strategies or market expansions does management plan to implement to reverse the top-line contraction in subsequent quarters?


































